TABLE 2.

Other Diagnoses and Medications Administered for Each Subject on the First Day of Pulmonary Embolism Presentation

Subject	Other Diagnoses and/or Recent Procedures Noted	Medications Administered	ESR Level,a mm/h	CRP Level,b mg/dL	D-Dimer Level,c ng/mL
1	Other venous embolism and thrombosis	Heparin	—	—	—
2	Overweight and obesity (BMI >40); asthma	Enoxaparin	61	2.7	1.3
3	None noted	Apixaban	—	—	0.94
4	Adverse effect of other estrogens and progestogens, initial encounter	Heparin and enoxaparin	—	—	—
5	Type 2 diabetes mellitus; overweight and obesity (BMI >40); and obstructive sleep apnea	Enoxaparin and hydrocortisone	—	—	—
6	Essential hypertension; other venous embolism and thrombosis; Wegener’s granulomatosis with renal involvement; and acute kidney failure; renal biopsy	Heparin	—	—	—
7	Elevated ESR; severe sepsis with shock; and encephalopathy, unspecified	Immunoglobulin G, methylprednisolone, and enoxaparin	37	281	—
8	Malignant neoplasm of long bones of left lower limb; acute myocardial infarction; cardiomyopathy; heart failure; intracardiac thrombosis, not elsewhere classified; acquired absence of left leg below knee; acute kidney failure; ascites; solitary pulmonary nodule; and laparoscopy	Enoxaparin and aspirind	—	—	—

CRP, C-reactive protein; —, not applicable.

^aESR reference range, 0 to 15 mm/h.

^bC-reactive protein reference range, <1 mg/dL.

^cD-dimer reference range, ≤0.54 ng/mL.

^dThese medications were reported to be administered 14 d after a pulmonary embolism diagnosis was reported.